News

Eli Lilly launches Mounjaro pen in India

Lilly launches Mounjaro pen in India at $160 for starting dose, stepping up Novo rivalry
Eli Lilly on Wednesday launched the easy-to-use injector pen of its blockbuster weight-loss drug Mounjaro for 14,000 rupees (nearly $160) for its starting dose of 2.5 mg in India, stepping up competition with Novo Nordisk.
Lilly launches Mounjaro pen in India at Rs. 14,000 for starting dose, stepping up Novo rivalry
Lilly said in June it received approval from India’s drug regulator for its once-weekly Mounjaro Kwikpen, two days after Novo Nordisk launched Wegovy in a similar pen device.
Lilly launches Mounjaro pen in India priced at $160
Eli Lilly launches injector pen for Mounjaro in India, Reuters reports
Eli Lilly (LLY) launched an injector pen for Mounjaro, its weight-loss drug, for 14,000 rupees, or $160, for its starting dose in India, Rishika
Eli Lilly launches Mounjaro pen in India as obesity drug race heats up
Eli Lilly has rolled out a prefilled pen version of its weight-loss drug Mounjaro at the same price as vials, aiming to capture India’s growing anti-obesity market as Novo Nordisk pushes Wegovy.
Eli Lilly begins commercial rollout of Mounjaro pen in India
Eli Lilly (NYSE:LLY) debuted its best-selling diabetes therapy, Mounjaro, in an easy-to-use injector format in India on Wednesday, escalating a rivalry with Novo Nordisk (NVO) in the world’s most populous country.

Mounjaro KwikPen by Lilly debuts in India at ₹14,000 for diabetes, obesity

Eli Lilly has launched its Mounjaro KwikPen in India at ₹14,000 for the 2.5 mg dose; the once-weekly injector targets ...
FoodNavigator-Asia17h

India Focus: Modi’s anti-obesity plan, better-for-you snacks, Zepto food scandal, and more

Modi’s nationwide anti-obesity drive, the rise of better-for-you snacks, Zepto e-commerce scandal, and more feature in this ...

Demand for obesity drugs shoots up in India as Lilly, Novo vie for market share

Demand for weight-loss drugs is rising at a fast clip in India, where rivals Eli Lilly and Novo Nordisk are competing for market share, data from research firm Pharmarack showed on Monday.
The Economist13d

Indian firms aim to gorge on weight-loss drugs

Indian pharma is hoping to cash in. Generic firms, such as Biocon, are already offering weight-loss drugs, such as cheaper ...
Rediff.com1d

Indian Pharma Majors Ready With Weight Loss Drugs

Prices for Indian consumers are expected to come down significantly from the current Rs 17,000-Rs 26,000 monthly.

India's Dr Reddy's plans to launch generic obesity drugs in 87 countries next year, CEO says

Dr Reddy's Laboratories plans to launch a cheaper copycat version of Novo Nordisk's blockbuster weight-loss drug Wegovy in 87 countries next year, the Indian drugmaker's CEO, Erez Israeli, said on ...
IndiaWest11d

Revenue Windfall Expected As Dr Reddy’s Lab Gears Up To Launch Generic Obesity Drug

HYDERABAD — Dr Reddy’s Laboratories is gearing up to enter the booming global obesity drug market with a more affordable ...
Insider Monkey1mon

Eli Lilly Mounjaro Sees Strong Reception in India, Rising Demand Amid ...

According to data from the research firm PharmaTrac, Mounjaro has sold over 81,570 units in India and made ~$2.76 million in revenue as of May. The drug’s sales increased by 60% between April ...
Reuters1mon

Novo and Lilly compete in India as obesity drugs demand hikes

July 7, 2025 Demand for weight-loss drugs is rising at a fast clip in India where rivals Eli Lilly and Novo Nordisk are competing for market share, data from research firm Pharmarack showed on ...